Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Bolt Biotherapeutics
BOLT
$7.78M
| $150K | ﹤0.01% |
18,756
+1,722
| +10% | +$16.5K |
|
|
BBOT
3927
BridgeBio Oncology
BBOT
$747M
| $150K | ﹤0.01% |
13,274
| – | – |
|
|
TRT
3928
Trio-Tech International
TRT
$113M
| $150K | ﹤0.01% |
49,958
+6,102
| +14% | +$18.5K |
|
3929
CareCloud
CCLD
$112M
| $149K | ﹤0.01% |
107,187
+574
| +0.5% | +$1.69K |
|
3930
XBP Global Holdings
XBP
$36.4M
| $149K | ﹤0.01% |
11,028
+1,091
| +11% | +$12.6K |
|
|
SVT
3931
DELISTED
Servotronics
SVT
| $147K | ﹤0.01% |
13,825
+677
| +5% | +$7.28K |
|
3932
Altisource Portfolio Solutions
ASPS
$65.8M
| $145K | ﹤0.01% |
26,589
+1,611
| +6% | +$9.89K |
|
3933
Spectral AI
MDAI
$55.7M
| $144K | ﹤0.01% |
125,593
+28,286
| +29% | +$52.2K |
|
|
CFSB
3934
DELISTED
CFSB Bancorp
CFSB
| $144K | ﹤0.01% |
18,816
+2,010
| +12% | +$15.2K |
|
3935
SunCar Technology Group
SDA
$86.7M
| $144K | ﹤0.01% |
34,865
| – | – |
|
3936
Calidi Biotherapeutics
CLDI
$3.96M
| $143K | ﹤0.01% |
1,312
+479
| +58% | +$87.4K |
|
|
ACB
3937
Aurora Cannabis
ACB
$185M
| $143K | ﹤0.01% |
32,486
| – | – |
|
3938
Lisata Therapeutics
LSTA
$9.55M
| $142K | ﹤0.01% |
60,529
+4,634
| +8% | +$12.5K |
|
3939
CXApp
CXAI
$17.5M
| $142K | ﹤0.01% |
157,928
+20,015
| +15% | +$28.2K |
|
3940
Sadot Group
SDOT
$12.7M
| $142K | ﹤0.01% |
264
+8
| +3% | +$4.99K |
|
3941
Cellectar Biosciences
CLRB
$20.5M
| $140K | ﹤0.01% |
14,781
+3,085
| +26% | +$27.9K |
|
3942
Sidus Space
SIDU
$229M
| $140K | ﹤0.01% |
94,301
+7,317
| +8% | +$16.7K |
|
3943
Solidion Technology
STI
$61.3M
| $139K | ﹤0.01% |
23,072
+1,377
| +6% | +$23.9K |
|
|
RENE
3944
DELISTED
Cartesian Growth Corp II
RENE
| $139K | ﹤0.01% |
11,687
| – | – |
|
|
DTCX
3945
Datacentrex Inc
DTCX
$79.7M
| $138K | ﹤0.01% |
34,225
+10,812
| +46% | +$36.9K |
|
3946
CKX Lands
CKX
$21.7M
| $137K | ﹤0.01% |
11,552
+896
| +8% | +$10.5K |
|
3947
BioVie
BIVI
$7.54M
| $135K | ﹤0.01% |
13,802
+1,461
| +12% | +$23.4K |
|
|
GLBZ
3948
DELISTED
Glen Burnie Bancorp
GLBZ
| $135K | ﹤0.01% |
26,588
+2,049
| +8% | +$10.5K |
|
|
AUTL
3949
Autolus Therapeutics
AUTL
$562M
| $134K | ﹤0.01% |
86,256
| – | – |
|
3950
Citius Pharmaceuticals
CTXR
$18.7M
| $133K | ﹤0.01% |
89,275
+12,769
| +17% | +$30.6K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.